MétaCan
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
→
Sort
Language
Type
Field
Venue
Topic
Prostate Cancer Treatment and Research
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

3,880 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
3,880 works in the cohort · of 4,299,418page 41 of 78

Labels cover 13 of 3,880 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 3,880 of 3,880 works in this cohort. Predictions are machine_predicted_unvalidated. The Gemma side is a direct model label for every work (title-only); the Codex side is a distilled, calibrated classifier. Candidate is the union; consensus is the intersection.

affno abstractunlabeled
Stereotactic Body Radiation Therapy for Oligometastasis: GUst Do It?
Rachel Glicksman, David A. Palma, Matthew P. Deek, C. Jillian Tsai, S.J. Chmura, Shankar Siva +3 more
2022· letter· en· International Journal of Radiation Oncology*Biology*Physics· Medicine
machine prediction:candidate · noneconsensus · none
4
citations
affunlabeled
Targeting defective DNA repair in prostate cancer
Juliet Carmichael, Maria D. Fenor de la Maza, Pasquale Rescigno, Khobe Chandran, Johann S. de Bono
2020· review· en· Current Opinion in Oncology· Medicine
machine prediction:candidate · noneconsensus · none
4
citations
affno abstractunlabeled
Survival outcomes for men with metastatic castration-resistant prostate cancer (mCRPC) with and without homologous recombination deficiencies (HRD) treated with radium 223: Princess Margaret Cancer Centre (PMCC) experience
Esmail Mutahar Al-Ezzi, Osama Abdeljalil, Katherine Lajkosz, Shreya S. Gramolini, Husam Alqaisi, Jenny Peng +8 more
2025· article· en· Urologic Oncology Seminars and Original Investigations· Medicine
machine prediction:candidate · noneconsensus · none
4
citations
afffundno abstractunlabeled
Variability in testosterone measurement between radioimmunoassay (RIA), chemiluminescence assay (CLIA) and liquid chromatography-tandem mass spectrometry (MS) among prostate cancer patients on androgen deprivation therapy (ADT)
Raj Tiwari, Katherine Lajkosz, MohamadBaker Berjaoui, Yazan Qaoud, Miran Kenk, Clive Woffendin +3 more
2022· article· en· Urologic Oncology Seminars and Original Investigations· Medicine
machine prediction:candidate · noneconsensus · none
4
citations
affno abstractunlabeled
In Regard to Freedland et al
Alejandro Berlín, Jenna Sykes, Alan Dal Pra, Charles Catton, Theodorus van der Kwast, Robert G. Bristow
2013· letter· en· International Journal of Radiation Oncology*Biology*Physics· Medicine
machine prediction:candidate · noneconsensus · none
4
citations

How this was built: Screen · Findings · About